India`s active pharmaceutical ingredient exports reach at Rs 41,493 crore in FY25: J P Nadda
Chemicals and Fertilizers Minister J P Nadda has said that India's active pharmaceutical ingredient (API) exports reached at Rs 41,493 crore in FY25, surpassing total API imports of Rs 39,215 crore. He said ‘so, it should be very clear that we are exporting more APIs than we are importing.’ He asserted that in the last 11 years, the central government has undertaken several key initiatives and policy measures to boost domestic production and reduce imports.
The minister said India's imports of APIs (bulk drugs, drug intermediates) stood at Rs 36,229 crore in FY23, Rs 37,721 crore in FY24 and Rs 39,214 crore in FY25. The imports from China were Rs 25,551 crore in FY23, Rs 27,055 crore in FY24 and Rs 29,064 crore in FY25. He said the share of China has increased to 74 per cent in FY25 from 70 per cent in FY23.
He further said the government has started a production linked incentive (PLI) scheme with an outlay of Rs 6,940 crore to promote the manufacturing of the key starting materials (KSM), drug intermediaries and the APIs, and to reduce import reliance on China. He said anti-dumping duty and minimum import price have been fixed to maintain the market. He added that the government is taking all comprehensive steps to make the nation self-reliant in the pharmaceutical sector.
